Bloomfield issues warning of vax-related heart issues

By Michael Coles

In a letter to all New Zealand health professionals working in the covid vaccine rollout, director-general of health Dr Ashley Bloomfield says they need to warn those rolling up their sleeves for the jab that myocarditis (heart inflammation) is a risk.

You can download the PDF letter here (please share it) – it’s just so disappointing Bloomfield issues the warning when 90% of the population has been vaccinated (many just to keep their jobs).

Bloomfield along with Dr Juliet Rumball-Smith, Dr Andrew Connolly, and Astrid Koornneef, signed the Urgent Warning letter on 15 December 2021 – just in time for prime minister Jacinda Ardern to be well out of the way of any awkward questions as Parliament went into the summer recess.

The letters states: “In response to recent reports of myocarditis/pericarditis following vaccination with Pfizer Comirnaty vaccine, the COVID-19 Vaccine Immunisation Programme is working to strengthen our system-level approach to ensure the best possible outcomes for our population should they experience this adverse event. 

“This is important information also for those who present with parents and caregivers…We do not yet have sufficient data in New Zealand around occurrence [of heart damage] after boosters.

“This letter is to request you to support us by leading a response in your region…Myocarditis and pericarditis have been established as very rare but serious adverse events associated with the Comirnaty vaccine.

“In New Zealand, the true incidence of vaccine-associated myocarditis is unknown as the onset of symptoms occurs in the first few days after vaccination and is potentially under-reported.

“However, the overall rate of this event in New Zealand is reported to be around 3 per 100,000 vaccinations.

“The international literature is helpful in identifying the demographic and clinical characteristics of those who are more likely to have this adverse event.

“However, the pattern of the reports to the Centre for Adverse Reactions Monitoring (CARM) in New Zealand is slightly different. Our data shows that clinically-validated myocarditis/pericarditis in the 30-days following the vaccine occurs:

  • Approximately equally in both males and females
  • Over a wide age range, with a median age of diagnosed cases in the mid-30s
  • Approximately equally after dose 1 and after dose 2

In this New Zealand data, the most common symptomatology described is:

  • Chest heaviness, discomfort, tightness or pain
  • Difficulty breathing, shortness of breath
  • Feeling dizzy, light-headed or faint
  • Racing or fluttering heart, or a feeling of ‘skipped beats’

The onset of these symptoms was usually in the first few days following the vaccine but can occur in the weeks later.

The letters concludes: “Finally, could we ask you to cascade the requirements across your provider network and confirm in writing that local planning and clinical leadership is in place to guide a local response to prevent the serious consequences of undiagnosed or untreated myocarditis/pericarditis.”

In other words – please tell everyone you know about Bloomfield’s tardy statement and confirm you have done this in writing.

Again, it’s worth noting that only 5% of all adverse reactions to the covid vaccine are reported to New Zealand’s adverse reaction database – CARM. There are two key reasons for this. Doctors are generally not inclined to acknowledge any connection between the vaccine and adverse reactions, and this maybe because to complete a CARM report can take about 30 minutes – and it is unpaid / voluntary.